↓ Skip to main content

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, July 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users
facebook
2 Facebook pages

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
Published in
Journal of Pharmaceutical Policy and Practice, July 2014
DOI 10.1186/2052-3211-7-8
Pubmed ID
Authors

Zaheer-Ud-Din Babar, Andy Gray, Ayyaz Kiani, Sabine Vogler, Peri Ballantyne, Shane Scahill

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 8%
South Africa 1 8%
Unknown 10 83%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 25%
Other 1 8%
Professor 1 8%
Student > Bachelor 1 8%
Student > Ph. D. Student 1 8%
Other 1 8%
Unknown 4 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 25%
Medicine and Dentistry 3 25%
Nursing and Health Professions 1 8%
Philosophy 1 8%
Unknown 4 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2015.
All research outputs
#12,707,910
of 22,759,618 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#198
of 405 outputs
Outputs of similar age
#101,164
of 225,828 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#3
of 5 outputs
Altmetric has tracked 22,759,618 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.